These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Bile acids with a cyclopropyl-containing side chain. 3. Separation, identification, and properties of all four stereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid. Pellicciari R; Natalini B; Cecchetti S; Porter B; Roda A; Grigolo B; Balducci R J Med Chem; 1988 Apr; 31(4):730-6. PubMed ID: 3351848 [TBL] [Abstract][Full Text] [Related]
9. Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid. Albini E; Marca G; Mellerio G Arzneimittelforschung; 1982; 32(12):1554-7. PubMed ID: 6891595 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Nakagawa M; Colombo C; Setchell KD Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new bile acid analogues and their metabolism in the hamster: 3 alpha, 6 alpha-dihydroxy-6 beta-methyl-5 beta-cholanoic acid and 3 alpha, 6 beta-dihydroxy-6 alpha-methyl-5 beta-cholanoic acid. Matoba N; Mosbach EH; Cohen BI; Une M; McSherry CK J Lipid Res; 1989 Jul; 30(7):1005-14. PubMed ID: 2794784 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid. Batta AK; Tint GS; Xu G; Shefer S; Salen G J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724 [TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acid esters of cheno- and ursodeoxycholic acids on gallstone formation in hamsters. Kritchevsky D; Klurfeld DM; Sirtori C Pharmacol Res Commun; 1986 Nov; 18(11):997-1002. PubMed ID: 3797448 [TBL] [Abstract][Full Text] [Related]
14. Development of a solid-phase enzyme immunoassay for ursodeoxycholic acid: application to plasma disappearance of injected ursodeoxycholic acid in the rabbit. Maeda Y; Setoguchi T; Katsuki T; Ishikawa E J Lipid Res; 1979 Nov; 20(8):960-5. PubMed ID: 392034 [TBL] [Abstract][Full Text] [Related]
15. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid. Maeda Y; Takahashi M; Tashiro H; Akazawa F J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease. Matern S; Marschall HU; Schill A; Schumacher B; Lehnert W; Sjövall J; Matern H Clin Chim Acta; 1991 Nov; 203(1):77-89. PubMed ID: 1769122 [TBL] [Abstract][Full Text] [Related]
17. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid. Maeda Y; Takahashi M J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of ursodeoxycholic acid and its deuterated derivative in human bile by gas chromatography-mass fragmentography. Tohma M; Nakata Y; Yamada H; Kurosawa T; Makino I; Nakagawa S Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):137-45. PubMed ID: 7261190 [No Abstract] [Full Text] [Related]
19. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid. Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066 [TBL] [Abstract][Full Text] [Related]
20. Bile acids with a cyclopropyl-containing side chain. 1. Preparation and properties of 3 alpha, 7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid. Pellicciari R; Cecchetti S; Natalini B; Roda A; Grigolo B; Fini A J Med Chem; 1984 Jun; 27(6):746-9. PubMed ID: 6737415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]